O’Shea, JJ, Paul, WE. Mechanisms Underlying lineage commitment and plasticity of helper CD4+ T cells. Science. 2010; 327: 1098–102.
Billingham, RE, Brent, L, Medawar, PB. Actively acquired tolerance of foreign cells. Nature. 1953; 172: 603–6.
Adkins, B, Leclerc, C, Marshall-Clarke, S. Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004; 4: 553–64.
Sarzotti, M, Robbins, DS, Hoffman, PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science. 1996; 271: 1726–8.
Ridge, JP, Fuchs, EJ, Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 1996; 271: 1723–6.
Forsthuber, T, Yip, HC, Lehmann, PV. Induction of TH1 and TH2 immunity in neonatal mice. Science. 1996; 271: 1728–30.
Marchant, A, Goldman, M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol. 2005; 141: 10–18.
Tavian, M, Péault, B. Embryonic development of the human hematopoietic system. Int J Dev Biol. 2005; 49: 243–50.
Hong, DK, Lewis, DB. Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection. In Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant, 8th edn. Philadelphia: Elsevier Saunders, 2016, pp. 90–197.
Willems, F, Vollstedt, S, Suter, M. Phenotype and function of neonatal DC. Eur J Immunol. 2009; 39: 26–35.
Lemoine, S, Jaron, B, Tabka, S, Ettreiki, C, Deriaud, E, Zhivaki, D, et al. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. J Allergy Clin Immunol. 2015; 136: 1355–1368. e15.
Salio, M, Dulphy, N, Renneson, J, Herbert, M, McMichael, A, Marchant, A, et al. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. Int Immunol. 2003; 15: 1265–73.
Rechavi, E, Somech, R. Survival of the fetus: fetal B and T cell receptor repertoire development. Semin Immunopathol. 2017; 39: 577–83.
White, GP, Watt, PM, Holt, BJ, Holt, PG. Differential patterns of methylation of the IFN-promoter at CpG and non-CpG sites underlie differences in IFN-gene expression between human neonatal and adult CD45RO-T cells. J Immunol. 2002; 168: 2820–7.
Zhang, X, Mozeleski, B, Lemoine, S, Deriaud, E, Lim, A, Zhivaki, D, et al. CD4 T Cells with effector memory phenotype and function develop in the sterile environment of the fetus. Sci Transl Med. 2014; 6: 238ra72.
Rechavi, E, Lev, A, Lee, YN, Simon, AJ, Yinon, Y, Lipitz, S, et al. Timely and spatially regulated maturation of B and T cell repertoire during human fetal development. Sci Transl Med. 2015; 7: 276ra25.
Suryani, S, Fulcher, DA, Santner-Nanan, B, Nanan, R, Wong, M, Shaw, PJ, et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood. 2010; 115: 519–29.
Griffin, DO, Holodick, NE, Rothstein, TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J Exp Med. 2011; 208: 67–80.
Vermijlen, D, Prinz, I. Ontogeny of Innate T lymphocytes – some innate lymphocytes are more innate than others. Front Immunol. 2014; 5: 486.
Dimova, T, Brouwer, M, Gosselin, F, Tassignon, J, Leo, O, Donner, C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci. 2015; 112: E556–65.
Michaëlsson, J, Mold, JE, McCune, JM, Nixon, DF. Regulation of T cell responses in the developing human fetus. J Immunol. 2006; 176: 5741–8.
Mold, JE, Michaëlsson, J, Burt, TD, Muench, MO, Beckerman, KP, Busch, MP, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008; 322: 1562–5.
Morand, A, Zandotti, C, Charrel, R, Minodier, P, Fabre, A, Chabrol, B, et al. De TORCH à TORCHZ: fœtopathies infectieuses à virus Zika et autres. Arch Pédiatrie. 2017; 24: 911–13.
Maldonado, YA, Nizet, V, Klein, JO, Remington, JS, Wilson, CB. Current concepts of infections of the fetus and newborn infant. In Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant, 8th edn. Philadelphia: Elsevier Saunders, 2016, pp. 3–23.
Renneson, J, Dutta, B, Goriely, S, Danis, B, Lecomte, S, Laes, J-F, et al. IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur J Immunol. 2009; 39: 2789–99.
Marchant, A, Appay, V, van der Sande, M, Dulphy, N, Liesnard, C, Kidd, M, et al. Mature CD8+ T lymphocyte response to viral infection during fetal life. J Clin Invest. 2003; 111: 1747–55.
Pédron, B, Guérin, V, Jacquemard, F, Munier, A, Daffos, F, Thulliez, P, et al. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis. 2007; 196: 1033–43.
Gibson, L, Piccinini, G, Lilleri, D, Revello, MG, Wang, Z, Markel, S, et al. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol. 2004; 172: 2256–64.
Miles, DJC, van der Sande, M, Jeffries, D, Kaye, S, Ismaili, J, Ojuola, O, et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol. 2007; 81: 5766–76.
Gibson, L, Dooley, S, Trzmielina, S, Somasundaran, M, Fisher, D, Revello, MG, et al. Cytomegalovirus (CMV) IE1‐ and pp65‐specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J Infect Dis. 2007; 195: 1789–98.
Pass, RF, Stagno, S, Britt, WJ, Alford, CA. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis. 1983; 148: 953–61.
Starr, SE, Tolpin, MD, Friedman, HM, Paucker, K, Plotkin, SA. Impaired Cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis. 1979; 140: 500–5.
Huygens, A, Lecomte, S, Tackoen, M, Olislagers, V, Delmarcelle, Y, Burny, W, et al. Functional exhaustion limits CD4+ and CD8+ T-cell responses to congenital cytomegalovirus infection. J Infect Dis. 2015; 212: 484–94.
Tu, W, Chen, S, Sharp, M, Dekker, C, Manganello, AM, Tongson, EC, et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol. 2004; 172: 3260–7.
Vermijlen, D, Brouwer, M, Donner, C, Liesnard, C, Tackoen, M, Van Rysselberge, M, et al. Human cytomegalovirus elicits fetal γδ T cell responses in utero. J Exp Med. 2010; 207: 807–21.
Brizić, I, Hiršl, L, Britt, WJ, Krmpotić, A, Jonjić, S. Immune responses to congenital cytomegalovirus infection. Microbes Infect. 2017; 20: 543–51.
Rovito, R, Korndewal, MJ, van Zelm, MC, Ziagkos, D, Wessels, E, van der Burg, M, et al. T and B cell markers in dried blood spots of neonates with congenital cytomegalovirus infection: B cell numbers at birth are associated with long-term outcomes. J Immunol. 2017; 198: 102–9.
Huygens, A, Dauby, N, Vermijlen, D, Marchant, A. Immunity to cytomegalovirus in early life. Front Immunol. 2014; 5: 552.
Noyola, DE, Fortuny, C, Muntasell, A, Noguera-Julian, A, Muñoz-Almagro, C, Alarcón, A, et al. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children: immunity to infection. Eur J Immunol. 2012; 42: 3256–66.
Shetty, A, Maldonado, YA. Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant. In Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant, 8th edn. Philadelphia: Elsevier Saunders, 2016, pp. 623–78.
Luzuriaga, K, Holmes, D, Hereema, A, Wong, J, Panicali, DL, Sullivan, JL. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol. 1995; 154: 433–43.
Thobakgale, CF, Ramduth, D, Reddy, S, Mkhwanazi, N, de Pierres, C, Moodley, E, et al. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J Virol. 2007; 81: 12775–84.
Lohman, BL, Slyker, JA, Richardson, BA, Farquhar, C, Mabuka, JM, Crudder, C, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol. 2005; 79: 8121–30.
Streeck, H, Nixon, DF. T cell immunity in acute HIV‐1 infection. J Infect Dis. 2010; 202: S302–8.
Voelkerding, KV, Sandhaus, LM, Belov, L, Frenkel, L, Ettinger, LJ, Raska, K. Clonal B-cell proliferation in an infant with congenital HIV infection and immune thrombocytopenia. Am J Clin Pathol. 1988; 90: 470–4.
Pugatch, D, Sullivan, JL, Pikora, CA, Luzuriaga, K. Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study. J Infect Dis. 1997; 176: 643–8.
Munoz, M, Liesenfeld, O, Heimesaat, MM. Immunology of Toxoplasma gondii. Immunol Rev. 2011; 240: 269–85.
Fatoohi, AF, Cozon, GJN, Wallon, M, Kahi, S, Gay-Andrieu, F, Greenland, T, et al. Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts. Eur J Clin Microbiol Infect Dis. 2003; 22: 181–4.
Ciardelli, L, Meroni, V, Avanzini, MA, Bollani, L, Tinelli, C, Garofoli, F, et al. Early and accurate diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2008; 27: 125–9.
Chapey, E, Wallon, M, Debize, G, Rabilloud, M, Peyron, F. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J Clin Microbiol. 2010; 48: 41–5.
Guglietta, S, Beghetto, E, Spadoni, A, Buffolano, W, Del Porto, P, Gargano, N. Age-dependent impairment of functional helper T cell responses to immunodominant epitopes of Toxoplasma gondii antigens in congenitally infected individuals. Microbes Infect. 2007; 9: 127–33.
McLeod, R, Mack, DG, Boyer, K, Mets, M, Roizen, N, Swisher, C, et al. Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med. 1990; 116: 623–35.
Hara, T, Ohashi, S, Yamashita, Y, Abe, T, Hisaeda, H, Himeno, K, et al. Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii. Proc Natl Acad Sci U S A. 1996; 93: 5136–40.
Carlier, Y, Truyens, C. Maternal–fetal transmission of Trypanosoma cruzi. In American Trypanosomiasis: Chagas Disease, 2nd edn. Amsterdam: Elsevier, 2017, pp. 517–59.
Hermann, E, Truyens, C, Alonso-Vega, C, Even, J, Rodriguez, P, Berthe, A, et al. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood. 2002; 100: 2153–8.
Hermann, E, Alonso-Vega, C, Berthe, A, Truyens, C, Flores, A, Cordova, M, et al. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells. Pediatr Res. 2006; 60: 38–43.
Rodriguez, P, Truyens, C, Alonso-Vega, C, Flores, A, Cordova, M, Suarez, E, et al. Serum levels for IgM and IgA antibodies to anti-trypanosoma cruzi in samples of blood from newborns from mothers with positive serology for Chagas disease. Rev Soc Bras Med Trop. 2005; 38 (Suppl. 2): 62–4.
Baud, D, Gubler, DJ, Schaub, B, Lanteri, MC, Musso, D. An update on Zika virus infection. Lancet. 2017; 390: 2099–109.
Weisblum, Y, Oiknine-Djian, E, Vorontsov, OM, Haimov-Kochman, R, Zakay-Rones, Z, Meir, K, et al. Zika Virus infects early- and midgestation human maternal decidual tissues, inducing distinct innate tissue responses in the maternal-fetal interface. J Virol. 2017; 91: e01905–16.
Yockey, LJ, Jurado, KA, Arora, N, Millet, A, Rakib, T, Milano, KM, et al. Type I interferons instigate fetal demise after Zika virus infection. Sci Immunol. 2018; 3: eaao1680.
Nem de Oliveira Souza, I, Frost, PS, França, JV, Nascimento-Viana, JB, Neris, RLS, Freitas, L, et al. Acute and chronic neurological consequences of early-life Zika virus infection in mice. Sci Transl Med. 2018; 10: eaar2749.
Dauby, N, Goetghebuer, T, Kollmann, TR, Levy, J, Marchant, A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis. 2012; 12: 330–40.
Abu Raya, B, Smolen, K, Willems, F, Kollmann, T, Marchant, A. Transfer of maternal anti-microbial immunity to HIV-exposed uninfected newborns. Front Immunol. 2016; 7: 338.
Slogrove, AL, Goetghebuer, T, Cotton, MF, Singer, J, Bettinger, JA. Pattern of infectious morbidity in HIV-exposed uninfected infants and children. Front Immunol. 2016; 7: 164.